Precipio Inc (PRPO): Mr. Kinnon continued, “From a financial...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Precipio Inc (PRPO)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	74
Posts	2650
Boards Moderated	0
Alias Born	10/17/2012

Re: None

Friday, 11/13/2015 5:15:24 PM

Friday, November 13, 2015 5:15:24 PM

Mr. Kinnon continued, “From a financial perspective, this is transition quarter, as we digest the major structural changes to our business. We have reduced expenses by more than $1 million per quarter and are now better positioned to focus on our MX-ICP technology. It is noteworthy that our laboratory business is up 18% this year on a stand-alone basis, but these gains were obscured in the third quarter due to seasonal and one-time factors. TBIO

My opinion is strictly that, an opinion. I can always be wrong. I am not affiliated with any stock nor any IR. [color=red][/color]

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PRPO News

Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:20:29 PM
Precipio Secures a short-term $500K Credit Facility • GlobeNewswire Inc. • 05/06/2024 09:00:00 PM
Precipio Announces Year end 2023 Shareholder Update Call • GlobeNewswire Inc. • 03/25/2024 09:00:00 PM
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY • GlobeNewswire Inc. • 02/13/2024 03:00:00 PM
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer • GlobeNewswire Inc. • 02/06/2024 03:00:00 PM
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter • GlobeNewswire Inc. • 01/23/2024 03:00:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/19/2024 09:05:44 PM
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan • GlobeNewswire Inc. • 01/17/2024 03:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:33:26 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:30:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:01:11 PM
Precipio Announces Christina Valauri joins the Board of Directors • GlobeNewswire Inc. • 01/02/2024 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:00:22 PM
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 • GlobeNewswire Inc. • 12/14/2023 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:15:16 PM
Precipio Announces Q3-2023 Shareholder Update Call • GlobeNewswire Inc. • 11/16/2023 10:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:03:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:30:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:30:25 PM
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 • GlobeNewswire Inc. • 10/18/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:34:18 PM
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 • GlobeNewswire Inc. • 10/03/2023 02:00:00 PM
Precipio Continues to Sign New HemeScreen™ Customers • GlobeNewswire Inc. • 09/28/2023 01:00:00 PM

More PRPO News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow